Published: Apr, 2018

The Asia preimplantation genetic diagnostic market manifests a scenario of intense competition owing to the presence of a large number of established players in the market. The market players are on a quest to increase their profit margins, which has brought them neck and neck in the race for market share. The competition is expected to further intensify over the coming years as the leading players resort to a range of strategies to establish their worth in the minds of the consumers. Furthermore, the market is highly fragmented on account of a large host of small-. Medium-, and large-scale service providers in the market. There are no significant barriers to the entry of new players which creates a situation of rapid entry and exit of small or local players. As regional market players enter the market, the bar of competition is expected to elevate to new heights over the coming years. It is anticipated that the Asian market for preimplantation genetic diagnostic would witness key product innovations over the course of the next few years. Perkin Elmer Inc., Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche, Natera Inc., and Abbott Laboratories are some of the key players operating in the Asian market.

The estimates outlined by the researchers at Transparency Market Research (TMR) reveal that the market for preimplantation genetic diagnosis in Asia would grow at a CAGR of 6.80% over the period from 2015 to 2023. The market was valued at US$16.0 mn in 2014 and is projected to touch a value of US$28.8 mn by the end of 2023. East Asia registered a high growth rate over the past years with a total opportunity worth US$ 6.0 mn in 2014.

preimplantation-genetic-diagnosis-market

Medical Tourism Aids Market Growth

Vitro-fertilization has emerged as a key reproductive procedure in Asia, which has given a boost to the demand within the regional market for preimplantation genetic diagnosis. Medical tourism has emerged as a key trend across the entire world, and Asia has become the prime destination to travel for globally-reckoned medical experts. This has played a major role in propelling demand within the Asian market for preimplantation genetic diagnosis.

Rising awareness about genetic disorders has persuaded the masses to resort to preimplantation genetic diagnosis, which has enhanced the growth of the regional market. Single gene disorder screening has replaced prenatal diagnostic testing due to the proven advantages of the former. Thereby, the Asian market is reaping commendable benefits from multiple avenues within the medical and healthcare sector.

Economic Advantage of Treatment to Bolster Demand

The healthcare industry in Asia has attracted a large host of patients from across the globe because of dual reasons. Primarily, the skill and proficiency of the medical practitioners in India and China has resulted in a greater success rate of medical treatments. Secondly, the costs of treatments in Asia are relatively lower than the rates in developed regions. It can be safely estimated that the market in Asia would tread along an immensely lucrative growth path over the course of the coming years.

The review is based on TMR report titled, “Preimplantation Genetic Diagnosis Market - Asia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023”.

The Asian market for preimplantation genetic diagnosis is segmented on this basis of the following parameters:

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Test Type

  • PGD for Aneuploidy Screening
  • PGD for Chromosomal Aberrations
  • PGD for Gender Selection
  • PGD for HLA Typing
  • PGD for Single Gene Disorder
  • PGD for X-linked diseases

Asia Preimplantation Genetic Diagnosis (PGD) Market, by End-user

  • Fertility Clinics
  • Health Care Facilities (including hospitals, diagnostic centers, and health care facilities)
  • Academic Institutes and Research Centers

Asia Preimplantation Genetic Diagnosis (PGD) Market, by Geography

  • South Eastern Asia
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Rest of SEA
  • Eastern Asia
    • China
    • Japan
    • South Korea
    • Rest of Eastern Asia
  • Southern Asia
    • India
    • Sri Lanka
    • Rest of Southern Asia
  • Central Asia
  • Western Asia
    • Israel
    • Turkey
    • Jordan
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Western Asia

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Website: https://www.transparencymarketresearch.com